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Abstract
Background: There is increasing interest in building the capacity of researchers in low and middle income
countries (LMIC) to address their national priority health and health policy problems. However, the number and
variety of partnerships and funding arrangements can create management problems for LMIC research institutes.
This paper aims to identify problems faced by a health research institute in Bangladesh, describe two strategies
developed to address these problems, and identify the results after three years of implementation.
Methods: This paper uses a mixture of quantitative and qualitative data collected during independent annual
reviews of the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) between 2006 and 2010.
Quantitative data includes the number of research activities according to strategic priority areas, revenues collected
and expenditure. Qualitative data includes interviews of researchers and management of ICDDR,B, and of research
users and key donors. Data in a Monitoring and Evaluation Framework (MEF) were assessed against agreed
indicators.
Results: The key problems faced by ICDDR,B in 2006 were insufficient core funds to build research capacity and
supporting infrastructure, and an inability to direct research funds towards the identified research priorities in its
strategic plan. Two strategies were developed to address these problems: a group of donors agreed to provide
unearmarked pooled core funding, and accept a single common report based on an agreed MEF. On review after
three years, there had been significant increases in total revenue, and the ability to allocate greater amounts of
money on capacity building and infrastructure. The MEF demonstrated progress against strategic objectives, and
better alignment of research against strategic priorities. There had also been changes in the sense of ownership
and collaboration between ICDDR,B’s management and its core donors.
Conclusions: The changes made to funding relationships supported and monitored by an effective MEF enabled
the organisation to better align funding with research priorities and to invest in capacity building. This paper
identified key issues for capacity building for health research in low and middle income countries. The findings
have relevance to other research institutes in similar contexts to advocate and support research capacity
strengthening efforts.
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Strengthening research capacity is considered one of the
most powerful, cost-effective, and sustainable means of
advancing health and development [1]. In the last two
decades, there has been an increased interest in building
and assessing health research capacity in developing
countries [2-10]. Capacity for health research is defined
as ‘an ability of individuals, organisations, or systems to
perform and utilise health research effectively, efficiently,
and sustainably’ [11]. This definition includes research
capacity at the level of individuals (training), organisa-
tions and systems.
According to Nchinda [2002], research capacity
strengthening consists of two main, closely inter-related
and inter-dependent activities: providing institutional sup-
port, and improving researcher capacity through appropri-
ate training. Building research capacity requires political
will and credibility, a responsive capacity-building plan,
leveraging, and cost sharing [2,12,13]. Research capacity is
still one of the constraints that prevents institutions in
developing countries from engaging in effective and essen-
tial research [5]. Building capacity for health research is a
complex and long-term process [1]. Inadequate support,
poor management and negative influences associated with
other external or internal factors can damage the research
capacities of institutions [1]. One of the factors required
for effective research infrastructure is the provision of
appropriate facilities that support researchers [14]. Finan-
cial and intellectual supports are also essential for building
effective and sustainable research institutions [15].
Trostle and Simon (1992) argued that research capacity
building is a development goal influenced by structural
constraints and cultural impediments among both donors
and recipients. Strengthening research capacity is mainly
an initiative of donor agencies located in developed coun-
tries [17,18]. However, the WHO, the Commission on
Health Research for Development, the Global Forum on
Health Research, the International Clinical Epidemiology
Network and other international agencies continue to
emphasise the need to strengthen capacity of research
institutions in developing countries [12,19-24].
A number of authors have highlighted the importance of
af a v o u r a b l ea n dc o n d u c i v ee n a b l i n ge n v i r o n m e n tf o r
research, in addition to good physical infrastructure
[1,10,25-27]. This includes factors such as: adequate funds
for researcher and staff salaries; training of individual
researchers; career structure for researchers; good research
management; equitable access to scientific and technical
information; partnerships between developed and develop-
ing countries; establishment of effective interfaces between
research producers and users; and competent and moti-
vated institutional leaders. These are the key challenges to
building research capacity in developing countries.
Strengthening research capacity in developing countries
is heavily dependent upon external investment [24].
Lansang and Dennis (2004) identify the need for greater
investment in research capacity building in developing
countries, and irrespective of the source, ‘a good propor-
tion is allocated to capacity building’. They suggest the
need to ‘document and analyse success and lessons learnt
from countries and organisations that have devised inno-
vative financing schemes for health research’.
Mayhew et al. (2008) concluded that capacity building
cannot be achieved without substantial financial input and
recommended that development partners should provide
long-term and in-country support for successful research
capacity building. Development partners need to be
focused and make coordinated efforts to achieve maximal
effect. Further research is needed to identify the best fund-
ing support to build capacity for research [28].
Simon J (2000) supported strengthening health research
capacity building in developing countries. He pointed out
that that there is little information available on the impact
of millions of dollars of investments for building research
capacity and indeed, little has been written on how
research capacity development efforts can be monitored
and evaluated. There is a lack of agreed indicators for
measuring progress or achievement, which are crucial to
evaluate the impact of investments on research capacity.
There is also a need to document the results and impacts
of different kinds of investment for development partners
and policy makers [29].
ICDDR,B
The International Centre for Diarrhoeal Disease Research,
Bangladesh (ICDDR,B) is a well established international
health research institute focusing primarily on research
that offers data for a wide range of disease areas to help
decision makers, especially in public health. Although the
information published and disseminated by ICDDR,B has
global utility, it specifically focuses on health issues that
are more relevant to low income countries. Since its estab-
lishment in 1960, ICDDR,B has been the recipient of
significant amounts of international donor funding to sup-
port its development and research projects. Over the past
50 years, the organisation has made significant contribu-
tions to expanding knowledge and service delivery practice
in health; in particular the development and introduction
of oral rehydration solution (ORS) for severe diarrhoea.
Despite valuable and constant financial support, a review
in 2006 observed that ICDDR,B faced a number of chal-
lenges in managing international funding in terms of
maintaining sustainable development and sustained
research contributions. The following article aims to assess
whether the interventions in management of donor sup-
port implemented in response to the review had enabled
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Methods
This research is based on a mixture of qualitative and
quantitative methods, using a case study approach. Qua-
litative data include key informant interviews as well as
a series of questionnaires with managers and key
researchers at ICDDR,B; with other research collabora-
tors; key funders; and potential users of research output,
including policy makers within the Ministry of Health,
Government of Bangladesh, and other national and
international development organisations operating in the
health sector. The research output from the organisation
was assessed in terms of coverage of identified research
priority areas, and the extent to which the research
addressed different phases of the development of inter-
ventions: basic and epidemiological research; causative
research; intervention research; and evaluation of imple-
mentation of interventions.
Quantitative data included counts of research outputs
and publications, patients treated at ICDDR,B’sc l i n i c a l
facilities, and numbers attending training courses and
sessions. It also included an analysis of ICDDR,B’s
finances, including income and expenditure. Data sources
included: (a) Annual reports published by ICDDR,B for
the years 2006-2010; (b) Monitoring and evaluation
reports prepared by the Monitoring and Evaluation Unit
of the organisation based on the indicators in the agreed
Monitoring and Evaluation Framework (years 2007-
2009); and (c) Annual external reviews of ICDDR,B con-
ducted by independent consultants for the years 2006 to
2009. (Author KH was the independent consultant for
the reviews of 2006 and 2010). During the reviews, quali-
tative data was collected through interviews, and the
assessments and reports prepared by the ME Unit of per-
formance against MEF indicators were reviewed. A sum-
mary of study areas of focus and data sources is provided
in Table 1
The ICDDR,B Monitoring and Evaluation Unit was
established in August 2007 with one coordinator and a
core team of four assistants liaising with designated divi-
sional staff who facilitate the compilation of requisite
information from the Principal Investigators (PIs). The
Unit collects, compiles and reports the data required to
assess the performance indicators included in the MEF.
Data were collected via a series of questionnaires devel-
oped by the MEF unit and entered by the designated divi-
sional staff onto a computer entry form.
Collated data were then meticulously analysed, modi-
fied or deleted by the MEF coordinator with the agree-
ment of the respective PI to avoid confounders and the
resulting information applied to the MEF tables. A final
scrutiny of the tables was carried out by the directors of
one of ICDDR,B’s four scientific divisions before sharing
with the core donors. From the pilot MEF in 2006, this
process was repeated each year and reports registered
and archived. The 2010 review evaluated the reports
from 2007, 2008 and 2009.
Results
Scope of activities undertaken by ICDDR,B
ICDDR,B is an international health research organisation
located in Dhaka, Bangladesh. Founded in 1960 as the
Pak-SEATO Cholera Research Laboratory, it was estab-
lished as an international organisation by an ordinance of
the Government of Bangladesh in 1978. It was originally
focused on cholera and other diarrhoeal diseases, and
related problems of nutrition and family planning. Since
then, its scope has broadened to include many of the
major public health disciplines and issues facing poor
countries: child health, infectious disease and vaccine
sciences, reproductive health, nutrition, population
sciences, health systems research, safe water, food safety,
HIV/AIDS and poverty and health [30].
ICDDR,B is primarily a research institution, and it main-
tains ongoing surveillance in regularly monitored urban
and rural communities, as well as conducting laboratory
research. It has a particular focus on a research pathway of
initial epidemiological research to identify changes in
population health; in depth studies to identify causes and
develop interventions; operational research on the imple-
mentation of interventions and evaluation studies of their
effectiveness. Examples include the development of oral
rehydration solution, and zinc treatment for diarrhoea.
ICDDR,B also provides training in topics such as
research methods, clinical management of diarrhoeal dis-
ease, laboratory methods, epidemiology and biostatistics,
family planning and demographic surveillance both to its
staff and to trainees from national, regional and interna-
tional institutions and individuals.
As part of its surveillance programme, and as a contri-
bution to the health of populations under surveillance,
ICDDR,B provides clinical services in the areas of its
expertise such as treatment of acute and persistent diar-
rhoea, nutrition rehabilitation of malnourished children,
treatment of acute respiratory infections, and treatment of
HIV-AIDS. The organisation also assists the agencies of
the Government of Bangladesh in investigating and
responding to outbreaks and epidemics of potentially
infectious disease.
Governed by a distinguished Board of Trustees (BOT)
comprising 17 multinational members, ICDDR,B’s devel-
opment is guided by a series of strategic plans, which iden-
tify research priorities, and capacity building objectives.
The majority of its funding is provided as research grants
for specific projects, provided by donors or through com-
petitive process. A few donors, including the Government
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Development (AusAID); the Canadian International
Development Agency (CIDA); the Department for Inter-
national Development (DFID) United Kingdom; the
Embassy of the Kingdom of the Netherlands (EKN); and
the Swedish Agency for International Development Coop-
eration (SIDA), provide funding for specific infrastructure
and capacity building activities, not directly linked to
research (core donors).
The 2006 Annual Review and Proposed changes
During the 2006 annual review of ICDDR,B, a number
of issues were identified, which were considered impor-
tant for the future development of research-based
funding.
ICDDR,B was receiving funding from around 55 differ-
ent donors and research granting bodies, each with their
own specific research interests, financing rules and regula-
tions, and reporting requirements. At the same time, the
organisation’s need for funding the underlying research
infrastructure and administrative and management sys-
tems (denoted as “core activities”) was growing. In order
to finance infrastructure development required to main-
tain research projects for donor organisations, ICDDR,B
requested a 30% management levy from the research
donors. However, many were reluctant to make this con-
tribution and, in addition, this levy proved unpopular with
the organisation’s researchers who felt that it made their
proposals less competitive. Only a few donors were pre-
pared to contribute ‘unearmarked’ funds or funding for
specific aspects of core activities.
ICDDR,B management felt that it was constrained in
pursuing the research priorities identified in its strategic
plan and was being tied to the interests of research
donors. Furthermore, the organisation’s capacity to invest
in developing and maintaining the physical and human
resource infrastructure needed to support research was
limited.
In consultation with the organisation’s management
team and the small group of donors prepared to invest in
core activities, referred to as the Core Donor Group
(CDG), the 2006 review proposed a change in the way
ICDDR,B and its CDG interacted. This change involved
the following: the core donors agreed to provide ‘unear-
marked’ funding to ICDDR,B to support its infrastructure
development and maintenance, and capacity building; the
organisation was required to report to the core donors on
the actual use of these funds through a single annual
financial report, and a single comprehensive report of pro-
gress in achieving the agreed indicators using a common
Monitoring and Evaluation Framework (MEF); and jointly,
the organisation and its core donors were to undertake an
annual review of core fund use reporting against the indi-
cators in the MEF.
Monitoring and Evaluation Framework (MEF)
The development of the MEF was a key requirement for
the funding changes to be made and it provided the agreed
framework for core donor commitment, as well as direct-
ing the future development of ICDDR,B, and creating a
tool allowing for measuring the progress. The main chal-
lenge was in reconciling the interests and priorities of the
donors with those of ICDDR,B. The organisation’s strate-
gic plan (2001-2010) at that time focused on identifying
priority research areas, and provided little guidance on the
directions or extent of capacity or infrastructure develop-
ment, or on the expected outcomes from research in those
identified priority areas. The CDG members were particu-
larly interested in ensuring that research addressed key
policy issues for health systems in low and middle income
countries (LMIC), and that the research findings were
communicated to policy users and, where appropriate,
influenced policy decisions.
The MEF, which was developed and agreed in 2007,
addresses the four key areas of ICDDR,B’s commitment:
research, clinical services, teaching, and improvements
Table 1 Areas of study, methods and data sources
Areas of Study Methods Data Sources
Context: perceived problems
and issues
Qualitative Interviews with ICDDR,B management; key donors; principal researchers
Quantitative Measurement of research output and topics;
Financial analysis
Intervention Qualitative Interviews with ICDDR,B management; key donors; principal researchers
Discussion with M&E unit
Quantitative Assessment of data provided against M&E indicators
Impact of intervention; changes
within ICDDR,B
Qualitative Interviews with ICDDR,B management; key donors; principal researchers
Discussion with M&E unit; Discussion among authors
Quantitative Measurement of research output
Financial analysis
Impact externally Qualitative Interviews with Government of Bangladesh policy makers; collaborating research institutes; other
national and international development agencies in Bangladesh
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outcomes, outputs and activities are nominated, with
indicators providing suitable measures. Where possible,
indicators are based on data already being collected at
ICDDR,B, or where the organisation has the capability
to collect the required data. Where available, the out-
comes and outputs in the MEF refer to the priorities
and development targets outlined in the Strategic Plan
(Table 2), The MEF approach was cited with approval
in Morris et al 2008 and this can become a key element
of performance reporting for organizations [31].
The 2010 Annual review and changes identified
The annual external review of 2010 was extended to
assess the effect of the changes recommended in 2006 on
ICDDR,B’s performance over the period 2007 to 2009
against the MEF indicators, and to evaluate, in more
d e p t h ,t h ec o n t r i b u t i o nm a d eb yc o r ef u n d i n gt ot h e
research carried out by ICDDR,B. The review identified
the following changes:
Changes in the relationship between core donors and the
ICDDR,B
Both the core donors (CD) and ICDDR,B management
reported a significant ‘qualitative’ change in the relation-
ship between each other. The CD functioned more as a
coherent group, rather than individually, facilitating collec-
tive communication and decision making. Frequent com-
munication and a good relationship with the chair of the
group of CD dramatically reduced the need for multiple
communications to each individual donor.
There had been a genuine attempt to maintain the
commitment to a single combined funding, and monitor-
ing and evaluation (M&E) process, despite some reserva-
tions. The single combined financial reporting had been
largely accepted, as well as the joint annual M&E review.
ICDDR,B management reported that the reduction in
reporting from quarterly to annual, and a single rather
than multiple-reporting format for the core donors had
reduced transaction costs, and led to further progress
towards harmonised and convergent management and
funding processes. From this collaborative approach on
behalf of the CD, a single consolidated funding request
process has been established. Core donors also reported
that the annual reporting process and single pooled fund-
ing contribution reduced their own costs in oversight and
supervision.
Interviews with ICDDR,B managers noted a marked
change in terms of ownership and control, with ICDDR,B
demonstrating much greater capacity and ability to con-
trol its own development, and preparedness to invest
core funds particularly in neglected areas in order to
build future capacity. This had not been possible in the
past, when development of research programmes and
capacity had been mainly ‘donor driven’.
The success of the first three years of the CD and
MEF has led to the development of a new strategic plan
for the period 2011-2020, which capitalizes on the posi-
tive outcomes of this new funding approach and incor-
porates the organisation’sp r i o r i t i e si n t ot h en e w
strategic plan with improved monitoring, evaluation and
reporting structures and processes.
Table 2 Summary of outcomes and outputs from MEF
Level Research Clinical Services Training Operation &
Management
Outcomes New knowledge relevant to global
and local health needs
Changes in programs, policies and
practices which incorporate this
knowledge
Contribution to health of
populations served
Knowledge of service needs &
clinical interventions
Local and regional health/research
workforce have improved skills and
knowledge in relevant areas
Incorporation of knowledge into
practice
Growth and development
of ICDDRB in line with
vision and mission
Maintain relevance of
ICDDRB to local, regional
and national context
Outputs Research agenda which identifies
priority research areas & objectives
Program of research activities
which is:
(a) in line with priorities in
strategic plan (SP)
(b) sensitive to issues of gender,
environment, poverty, & equity
(c) credible and high quality
based on sound methodology &
innovation
(d) conducted according to ethical
standards with benefit for research
participants
Users and decision makers in
relevant areas informed of
research findings & implications
Effective treatment is provided
to patients
Equity in access to services
appropriate to need
Efficient use of resources in
provision of services
Quality of clinical services
maintained and risks to
patients and staff minimised
Research results and findings
relevant to clinical services
Training program based on workforce
needs and ICDDR,B areas of
contribution
Course participants have knowledge
and improved skills in relevant areas
Quality: Knowledge and skills based on
relevant evidence and effective
teaching methods
Increase in total and externally
provided funds for training.
Governance and decision
making provides effective
leadership
Efficient & effective
financial management
Effective management of
partnerships with donors
Effective management and
development of human
resources
Maintenance and
development of facilities
and infrastructure
Effective information
management
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T h eM E Fh a sb e e nu s e da st h eb a s i sf o ra n n u a lr e p o r t -
ing and reviews for the years 2007, 2008 and 2009, with
modifications being made on an on-going basis in line
with developments in the collection and compilation of
data, and new developments in services and research
interests.
The quality of reporting and the information provided in
the MEF report has improved progressively, and in the
2010 review, the 2009 data was either good or sufficient in
terms of performance assessment against 80% of related
indicators. The main weaknesses in reporting were exces-
sive detail, lack of focus on priority areas or significant
results, and lack of comparative analysis. Reporting against
outcomes, particularly in the areas of research and clinical
services, was found to be poor, and recommendations
were given as a means to strengthen this element.
However, the interviews found some differences in the
perception of managers and researchers (especially princi-
pal investigators) regarding the MEF. While managers saw
t h eb e n e f i t si nt e r m so fs a v i n g si nt r a n s a c t i o nc o s t s ,a n d
greater autonomy in use of funds, researchers tended to
view it as an additional donor requirement and of little
benefit to them personally. It was clear that some of this
alienation was due to ICDDR,B’s existing structure. With
this in mind, the new Strategic Plan 2020 includes a signif-
icant restructuring to better align researchers with the
strategic priorities of the organisation, and their reporting
with the MEF.
Performance in key areas of research, clinical services,
training and capacity building, management, and
operations
The review found that ICDDR,B has continued to perform
well in all areas (Table 3). In terms of research, the review
documented significant research findings, and incorpora-
tion of these findings into international policy and national
programme guidelines in five of the priority research areas,
as described in the Strategic Plan, 2001-2010. In particular,
the interviews with external stakeholders identified that
ICDDR,B researchers employed a range of mechanisms
for disseminating information and policy engagement, and
that building relationships between researchers and policy
makers had been key to influencing policy in the complex
and dynamic political environment of Bangladesh.
The number of patients treated through clinical ser-
vices increased while there were also improvements in
the range of services and standard of care provided.
Increases in the number and range of training provided,
particularly for ICDDR,B staff and for GoB agencies,
were also highlighted in the review. The number trained
in research skills increased from 36 in 2007 to 120 in
2009 with 40% of participants being female, while the
number trained in clinical skills remained between 120
and 130 per year, with the proportion of female trainees
increasing from 20% to 30%.
In the area of management and operations, ICDDR,B
achieved two of the six priorities identified in the 2001-
2010 Strategic Plan, namely reaching the financial target
of US$30 million annual gross income; and the introduc-
tion of a computerised financial management system.
The remaining four priorities appeared to be making sig-
nificant progress, including introduction of IT applica-
tions, extension of the main ICDDR,B building to 8
floors, and transition in HR management from the UN
system to a competency-based system.
There was significant progress in the area of human
resource management, with the establishment of an HR
development unit, the development and implementation
of a specific gender policy, an assessment of organisation-
wide training needs, and the expansion of training pro-
vided to staff in identified priority areas: English language;
computer applications; and scientific writing.
Contribution of core funds to ICDDR,B
Against continuing increases in total funding for the orga-
nisation, which increased from $23.15 million to $38.69
million between 2006 and 2009, the proportion of total
revenue represented by core funds increased from 25% to
nearly 40%, a figure that has since remained relatively
steady. Total core donor funding in 2009 was $14,099,000
of which the CD contributed $13,070,000 (94%) At the
same time research grant and project income has also
increased, from $13.3 million in 2006, to $23.1 million in
2010, an increase of nearly 75% (Table 4).
There were some changes in relationships with other
donors that contributed to this improved financial per-
formance, including agreement by the Government of
Bangladesh to provide funding for new capital works, and
to channel funding from the Health Sector Support Pro-
ject to ICDDR,B; and relaxation in the requirements for
funding from USAID that enabled ICDDR,B to receive
USAID funding after a period when family planning
restrictions had prevented it.
Total core expenditure, including core capital expendi-
ture, increased by 31% between 2007 and 2009. The
amount contributed by core donor funding rose slightly
from 78% in 2007 to 81% in 2009; the remaining 19-20%
was derived from management levies, research project
funds, and other receipts. The 80% core expenditure cov-
ered by CD funds comprises a combination of opera-
tional/recurrent expenditure, plus investment in new
systems, processes and equipment (Table 4).
Core funds have also been used to support research in
new areas while research proposals and capacity building
are being encouraged and developed (e.g. in health sys-
tems). Direct funding of research from core funds
remains relatively small at only 5% of total research
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research grants are difficult to attract; strategic pilot or
‘seed’ research, which has attracted grants at a later stage;
and building capacity of young career researchers.
Principally, core funds were allocated to build research
infrastructure, in terms of systems, human resources,
and equipment. This is a key area in which it was pre-
viously difficult for ICDDR,B to invest, due to the con-
straints imposed by specific research project funding.
However, the core contribution has significantly
improved ICDDR,B’s future capacity to retain and
develop new researchers, and to compete for and gain
competitive research grants
Discussion
While this review only documented changes over a three
year period, it suggests that the changes to the funding
and reporting arrangements between the core donors
and ICDDR,B has had a significant impact on the pro-
blems identified in the 2006 review.
In particular, ICDDR,B management feels that the new
funding arrangement has increased autonomy to pursue
its identified strategic priorities; has enabled the organi-
sation to invest in research infrastructure and workforce
capacity development; and has maintained its success in
obtaining research grants and project funding. These
investments have focused on human resource develop-
ment at ICDDR,B, which is consistent with the litera-
ture, with development of ‘the capabilities of scientists
to undertake quality research’ being one of the two
Table 3 Research outcomes and key indicators and achievement
Outcome/output Indicators Achievement (2009)
Outcome
1. New knowledge relevant to global and local
health needs
Implications of research findings or results for
current knowledge/understanding or programs/
interventions in relation to MDGs or national
priorities.
Review of progress and policy development
demonstrates significant contributions in 6/8
priority areas of Strategic Plan 2001-2010
2. Changes in programs, policies and practices
which incorporate this knowledge
Changes in national/regional or international
policy/programs consistent with new knowledge/
research findings.
Significant policy changes/policy
contribution in 5/8 priority areas of Strategic
Plan 2001-2010
Outputs
1. Updated research agenda which identifies
priority research areas & objectives
Revisions to the priority research areas based on
consultation with stakeholders and research
findings undertaken at least every 2 years.
Strategic Plan 2010-2020 provides
information on new research directions and
justification
2. Program of research protocols and research
activities which contribute to the objectives in
the priority research areas identified in the
Strategic Plan
Number of new research protocols/activities
approved by research priority area and research
phase during the last 12 months
Increase in infections (27%), health systems
(17%); decrease in diarrhoea (9%) and HIV
(8%)
Shift towards operational research
3. Research program addresses issues of gender,
environment, poverty and equity where relevant.
No/% of protocols approved during the last 12
months which address - gender, environment,
poverty and equity.
Very low proportions - no significant change
over 2007-2009 periods. Reporting is not
capturing this information.
4. Research undertaken by ICDDR,B is regarded as
high quality and innovative by international
peers.
No. of publications in the high impact peer
reviewed journals by research priority area during
last 12 months.
Most in traditional strong areas of diarrhoea
(1/3), infections, child health
No. of citations in peer reviewed literature for key
publications in each priority research area over a 5
year period.
Citation rate by area:
highest in diarrhoea (7.3); infectious disease
(4.9); child health (4.5)
5. Research undertaken by ICDDR,B is conducted
according to ethical standards
Presence of policies on scientific misconduct,
acknowledgement, authorship, sex trafficking,
allocation core funds
Policies established, but compliance not
known
Numbers and proportion of investigators certified
for human research
Proportion has risen to 97% from low levels
in previous years
Table 4 Revenue and expenditure by year (USD ‘000)
Revenue type 2006 2007 2008 2009
Research projects 13,307 16,674 20,906 23,065
Un-earmarked core funds 7,205 10,393 11,782 14,099
Other* 2,638 1,820 1,953 1,530
Total** 23,150 28,887 34,642 38,694
Operating Expenditure**
Research projects 13307 16674 20906 23065
Core funded research 301 895 804 964
Clinical services 2238 2747 4315 5323
Management systems 2747 4019 2906 3292
Infrastructure/research support/capacity
building
3390 5227 5179 5718
Total 21983 28756 34450 38598
*Includes management levy from research funding
** Excludes capital expenditure.
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Nchinda [10].
The use of core funds as ‘seed’ funds for developing
research proposals is one way that ICDDR,B has
addressed the problem alluded to by Sitthi-amorn and
Somrongthong [9] as “the ‘brain drain’ of scientists and
researchers to developed countries”.T h es e e df u n d s
enabled returning PhD students to commence their
careers as researchers, without having to wait until they
could win research grants through their own initiatives.
There have also been efficiency savings in terms of
reduction in multiple reporting and communication with
multiple donors, and continued growth in total revenue
from both research grants and core funding. While other
changes in the operating context such as the increased
funding from the Government of Bangladesh and USAID
clearly contributed, it is likely that the increased invest-
ment in infrastructure and human resources assisted
ICDDR,B in responding to these new opportunities.
The effectiveness of the core funding mechanism is
dependent on a common and agreed strategy, and an
effective MEF to measure, monitor and evaluate progress
in achieving the strategic elements. Establishing such a
framework in the context of a research institute is chal-
lenging, as researchers traditionally value autonomy in
pursuing their research objectives, rather than being
guided by institutional strategy and key performance
indicators.
While the principal focus of the MEF has been on
reporting to donors, ICDDR,B management have been
keen to use the MEF to improve monitoring and reporting
within the organisation on achievement of the Strategic
Plan priorities. The establishment of the M&E Unit, and
the regular annual reviews have imposed additional costs
on both ICDDR,B and donors, but also enabled them to
periodically revise and improve the MEF.
Authors of other published articles have commented
o nt h ed i f f i c u l t yo fi d e n t i f y i ng appropriate indicators for
measuring research capacity building. Commonly mea-
sured outcomes include publications in peer-reviewed
journals, successful grant applications, qualifications of
the researchers, projects per year, projects per researcher,
project duration of greater than one year, and conference
presentations [3,25,28,32]. As Cooke (2005) noted, these
‘traditional outcomes may not address all the relevant
issues to highlight progress’ in research capacity building.
In particular, she notes the need to address the suppor-
tive environment, usefulness or social impact of research,
and professional outcomes [32].
The experience at ICDDR,B confirms the importance
of an agreed MEF, with indicators that capture the full
breadth of the organisation’s activities, and are sensitive
to the capacity building efforts. The elements of the MEF
reflect the six principles proposed by Cooke (2005) [32]:
developing skills and confidence; supporting links and
partnerships; ensuring that research is ‘close to practice’;
developing appropriate dissemination; investing in infra-
structure; and building elements for sustainability and
continuity. ICDDR,B’s clinical services provide the
opportunity for research that is ‘close to practice’,w h i l e
the management and operations’ section addresses infra-
structure, and sustainability and continuity.
Conclusions
While this paper reports on the experience of one
research institute in a developing country context, there
are three key issues which we believe are of relevance to
other institutes in similar contexts:
(1) Investment in capacity building and maintaining
physical and human resource infrastructures of research
institutes is vital to their sustained operation. However,
adequate funding for these needs cannot be obtained
through funding for specific research projects or
through research grants, even with a ‘management levy’.
(2) Part of this capacity is the ability and autonomy of
the research institute to determine its own strategic
growth and research priorities, and to invest in pursuing
these, rather than the priorities determined by research
funders.
(3) The provision of unearmarked core funding for use
by the research institute to invest in the agreed strategic
priorities is a potential mechanism to build this capacity
and to maintain this autonomy. In many ways, this
situation is comparable to that of the governments of
low income countries when dealing with donors, with
the process established at ICDDR,B has been likened to
a ‘mini SWAPs (Sector Wide Approaches)’, consistent
with the principles of the Paris Declaration on Aid
Effectiveness [33].
However, as in SWAps, there is a need for significant
capacity on the part of the research institute to manage
and operate such a mechanism. This includes the devel-
opment of its own strategic plan and identification of
investment priorities; the ability to manage and report on
use of the funds in a financially accountable manner; and
the ability to report on results through an agreed M&E
framework. Underlying this is the need for confidence
and a strong relationship between the research institute
and its donors, that allows for robust dialogue and the
resolution of differences.
ICDDR,B has been fortunate in having a long period
of interaction with donors prior to the establishment of
this mechanism in which to build up this capacity, and
to develop these relationships.
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